TABLE 4.
Clinicopathologic parameters | Outcome | ||||
---|---|---|---|---|---|
pT | Fuhrman | Size | DSS | Progression | |
pT | N/A | N/A | N/A | 0.0008 | 0.0001 |
Fuhrman | N/A | N/A | N/A | NS | NS |
Gender | N/A | N/A | N/A | NS | NS |
Size | N/A | N/A | N/A | 0.0001 | 0.0001 |
| |||||
Biomarkers expression | |||||
| |||||
PTEN | 0.032 | NS | NS | NS | NS |
phos-AKT | 0.004 | NS | NS | NS | NS |
phos-S6 | 0.0004 | NS | NS | 0.0001 | 0.0001 |
4EBP1 | 0.036 | NS | 0.025 | 0.0152 | 0.0025 |
c-MYC | 0.008 | NS | NS | NS | NS |
p27 | 0.0001 | 0.031 | 0.0001 | 0.031 | 0.0093 |
HIF-1α | 0.016 | NS | 0.009 | 0.0009 | 0.0007 |
ccRCC: clear cell renal cell carcinoma; DSS: Disease-Specific Survival; N/A: not applicable; NS: nonsignificant (P>0.05)